{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:36Z","timestamp":1792793916924,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T00:00:00Z","timestamp":1754179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12851-5","type":"journal-article","created":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:27:29Z","timestamp":1754263649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of IL-10 gene promoter polymorphisms and haplotypes between high-grade squamous intraepithelial lesions or cervical cancer and negative cervical cytology"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7085-8788","authenticated-orcid":false,"given":"Amaxsell Thiago Barros","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Luisa","family":"de Sousa Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-099X","authenticated-orcid":false,"given":"Fernanda Silva","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2650-4365","authenticated-orcid":false,"given":"Kleyton Thiago Costa","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-3599","authenticated-orcid":false,"given":"George Alexandre","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-1344","authenticated-orcid":false,"given":"Ricardo Ney","family":"Cobucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-3800","authenticated-orcid":false,"given":"Kassio Michell Gomes","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-1794","authenticated-orcid":false,"given":"Norma","family":"Lucena-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-9601","authenticated-orcid":false,"given":"Eduardo Ant\u00f4nio","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-0078","authenticated-orcid":false,"given":"Janaina Cristiana","family":"de Oliveira Crispim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,3]]},"reference":[{"issue":"06","key":"12851_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21609","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68 (06), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21609 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"12851_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3892\/ol.2015.2884","volume":"9","author":"JV Fernandes","year":"2015","unstructured":"Fernandes, J. V. et al. Link between chronic inflammation and human papillomavirus-induced carcinogenesis. Oncol. Lett. 9 (3), 1015\u20131026. https:\/\/doi.org\/10.3892\/ol.2015.2884 (2015).","journal-title":"Oncol. Lett."},{"issue":"10","key":"12851_CR3","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/microorganisms9102092","volume":"9","author":"H Espinoza","year":"2021","unstructured":"Espinoza, H., Ha, K. T., Pham, T. T. & Espinoza, L. Genetic predisposition to persistent human Papillomavirus-Infection and Virus-Induced cancers. Microorganisms 9 (10), 2092. https:\/\/doi.org\/10.3390\/microorganisms9102092 (2021).","journal-title":"Microorganisms"},{"issue":"4","key":"12851_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41416-020-01184-x","volume":"124","author":"TR Litwin","year":"2021","unstructured":"Litwin, T. R. et al. Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis. Br. J. Cancer. 124 (4), 831\u2013841. https:\/\/doi.org\/10.1038\/s41416-020-01184-x (2021).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"12851_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-3083.2011.02662.x","volume":"75","author":"LX Wang","year":"2012","unstructured":"Wang, L. X. et al. IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours. Scand. J. Immunol. 75 (3), 273\u2013281. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02662.x (2012).","journal-title":"Scand. J. Immunol."},{"key":"12851_CR6","doi-asserted-by":"publisher","unstructured":"Singh, S., Sharma, A. & Arora, S. K. Combination of low producer AA-genotypes in IFN-\u03b3 and IL-10 genes makes a high risk genetic variant for HIV disease progression. Cytokine 77, 135\u2009\u2013\u200944 (2016). https:\/\/doi.org\/10.1016\/j.cyto.2015.11.009","DOI":"10.1016\/j.cyto.2015.11.009"},{"key":"12851_CR7","doi-asserted-by":"publisher","unstructured":"Prata, T. T. et al. Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunology 146(1), 113\u2009\u2013\u200921 (2015). https:\/\/doi.org\/10.1111\/imm.12487","DOI":"10.1111\/imm.12487"},{"issue":"1","key":"12851_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000471899","volume":"42","author":"J Gao","year":"2017","unstructured":"Gao, J. et al. Association of Interleukin-10 polymorphisms (rs1800872, rs1800871, and rs1800896) with predisposition to IgA nephropathy in a Chinese Han population: A Case-Control study. Kidney Blood Press. Res. 42 (1), 89\u201398. https:\/\/doi.org\/10.1159\/000471899 (2017).","journal-title":"Kidney Blood Press. Res."},{"key":"12851_CR9","doi-asserted-by":"publisher","unstructured":"Lee, B. R. et al. Interleukin-10 attenuates tumour growth by inhibiting interleukin-6\/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells. Cancer Lett. 381 (1), 156\u2009\u2013\u200964,. https:\/\/doi.org\/10.1016\/j.canlet.2016.07.012 (2016).","DOI":"10.1016\/j.canlet.2016.07.012"},{"issue":"2","key":"12851_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cei.12059","volume":"172","author":"L Sun","year":"2013","unstructured":"Sun, L. et al. Dual role of interleukin-10 in the regulation of respiratory syncitial virus (RSV)-induced lung inflammation. Clin. Exp. Immunol. 172 (2), 263\u2013279. https:\/\/doi.org\/10.1111\/cei.12059 (2013).","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"12851_CR11","doi-asserted-by":"publisher","first-page":"e57246","DOI":"10.1371\/journal.pone.0057246","volume":"8","author":"Q Ding","year":"2013","unstructured":"Ding, Q. et al. The interleukin-10 promoter polymorphism rs1800872 (-592C\u2009>\u2009A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls. PLOS One. 8 (2), e57246. https:\/\/doi.org\/10.1371\/journal.pone.0057246 (2013).","journal-title":"PLOS One"},{"issue":"7","key":"12851_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/107999099313532","volume":"19","author":"S Huang","year":"1999","unstructured":"Huang, S., Huang, S., Ullrich, S. E. & Bar-Eli, M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res. 19 (7), 697\u2013703. https:\/\/doi.org\/10.1089\/107999099313532 (1999).","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"12851_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/path.929","volume":"195","author":"AM El-Sherif","year":"2001","unstructured":"El-Sherif, A. M., Seth, R., Tighe, P. J. & Jenkins, D. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J. Pathol. 195 (2), 179\u2013185. https:\/\/doi.org\/10.1002\/path.929 (2001).","journal-title":"J. Pathol."},{"issue":"3","key":"12851_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1525-1438.2005.00433.x","volume":"15","author":"M Zoodsma","year":"2005","unstructured":"Zoodsma, M. et al. Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int. J. Gynecol. Cancer. 15 (3), 282\u2013290. https:\/\/doi.org\/10.1111\/j.1525-1438.2005.00433.x (2005).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"12851_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/03014460.2014.1001436","volume":"43","author":"MC Tavares","year":"2016","unstructured":"Tavares, M. C. et al. Tumor necrosis factor (TNF) alpha and Interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion. Ann. Hum. Biol. 43 (3), 261\u2013268. https:\/\/doi.org\/10.3109\/03014460.2014.1001436 (2016).","journal-title":"Ann. Hum. Biol."},{"issue":"1","key":"12851_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-014-0165-4","volume":"71","author":"Y Jin","year":"2015","unstructured":"Jin, Y. Association of single nucleotide polymorphisms in tumor necrosis factor-alpha with cervical cancer susceptibility. Cell. Biochem. Biophys. 71 (1), 77\u201384. https:\/\/doi.org\/10.1007\/s12013-014-0165-4 (2015).","journal-title":"Cell. Biochem. Biophys."},{"key":"12851_CR17","doi-asserted-by":"publisher","first-page":"107091","DOI":"10.1016\/j.intimp.2020.107091","volume":"89","author":"A Datta","year":"2020","unstructured":"Datta, A. et al. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. Int. Immunopharmacol. 89, 107091. https:\/\/doi.org\/10.1016\/j.intimp.2020.107091 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"12851_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cyto.2015.05.028","volume":"76","author":"S Zidi","year":"2015","unstructured":"Zidi, S. et al. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians. Cytokine 76 (2), 343\u2013347. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.028 (2015).","journal-title":"Cytokine"},{"issue":"2","key":"12851_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s002510050250","volume":"46","author":"J Eskdale","year":"1997","unstructured":"Eskdale, J., Kube, D., Tesch, H. & Gallagher, G. Mapping of the human IL10 gene and further characterization of the 5\u2019 flanking sequence. Immunogenetics 46 (2), 120\u2013128. https:\/\/doi.org\/10.1007\/s002510050250 (1997).","journal-title":"Immunogenetics"},{"key":"12851_CR20","doi-asserted-by":"publisher","first-page":"12365","DOI":"10.18632\/oncotarget.24193","volume":"9","author":"C Guo","year":"2018","unstructured":"Guo, C. et al. Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis. Oncotarget 9, 12365\u201312375. https:\/\/doi.org\/10.18632\/oncotarget.24193 (2018).","journal-title":"Oncotarget"},{"issue":"8","key":"12851_CR21","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00432-020-03256-0","volume":"146","author":"APL Pereira","year":"2020","unstructured":"Pereira, A. P. L. et al. IL-10 c.-592C\u2009>\u2009A (rs1800872) polymorphism is associated with cervical cancer. J. Cancer Res. Clin. Oncol. 146 (8), 1971\u20131978. https:\/\/doi.org\/10.1007\/s00432-020-03256-0 (2020).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"12851_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.intimp.2018.11.015","volume":"66","author":"GH Du","year":"2019","unstructured":"Du, G. H., Wang, J. K., Richards, J. R. & Wang, J. J. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int. Immunopharmacol. 66, 154\u2013161. https:\/\/doi.org\/10.1016\/j.intimp.2018.11.015 (2019).","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"12851_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.TP.0000055216.19866.9A","volume":"75","author":"A Su\u00e1rez","year":"2003","unstructured":"Su\u00e1rez, A., Castro, P., Alonso, R., Mozo, L. & Guti\u00e9rrez, C. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75 (5), 711\u2013717. https:\/\/doi.org\/10.1097\/01.TP.0000055216.19866.9A (2003).","journal-title":"Transplantation"},{"issue":"1","key":"12851_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner, D. M. et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24 (1), 1\u20138. https:\/\/doi.org\/10.1111\/j.1365-2370.1997.tb00001.x (1997).","journal-title":"Eur. J. Immunogenet."},{"key":"12851_CR25","doi-asserted-by":"publisher","unstructured":"Govan, V. A. et al. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J. Carcinog. 2 (1), 3. https:\/\/doi.org\/10.1186\/1477-3163-2-3 (2003).","DOI":"10.1186\/1477-3163-2-3"},{"key":"12851_CR26","doi-asserted-by":"publisher","unstructured":"Netea, M. G. & Wijmenga, C. O\u2019Neill, L.A.J. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 13 (6), 535\u2009\u2013\u200942. https:\/\/doi.org\/10.1038\/ni.2284 (2012).","DOI":"10.1038\/ni.2284"},{"key":"12851_CR27","doi-asserted-by":"publisher","unstructured":"Lettre, G. & Rioux, J. D. Autoimmune diseases: insights from genome-wide association studies. Hum. Mol. Genet. 17 (R2), R116-21. https:\/\/doi.org\/10.1093\/hmg\/ddn246 (2008).","DOI":"10.1093\/hmg\/ddn246"},{"issue":"1","key":"12851_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","volume":"133","author":"BC Hamidullah","year":"2012","unstructured":"Hamidullah, C.B. & Konwar, R. Role of interleukin-10 in breast cancer. Breast Cancer Res. Treat. 133 (1), 11\u201321. https:\/\/doi.org\/10.1007\/s10549-011-1855-x (2012).","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"12851_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1158\/0008-5472.CAN-10-4627","volume":"72","author":"T Tanikawa","year":"2012","unstructured":"Tanikawa, T. et al. Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res. 72 (2), 420\u2013429. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4627 (2012).","journal-title":"Cancer Res."},{"issue":"14","key":"12851_CR30","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"8","author":"V Carlini","year":"2023","unstructured":"Carlini, V. et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. 8 (14), 1161067. https:\/\/doi.org\/10.3389\/fimmu.2023.1161067 (2023).","journal-title":"Front. Immunol."},{"key":"12851_CR31","doi-asserted-by":"publisher","unstructured":"Zheng, L. M. et al. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism. J. Exp. Med. 184 (2), 579\u2009\u2013\u200984. https:\/\/doi.org\/10.1084\/jem.184.2.579 (1996).","DOI":"10.1084\/jem.184.2.579"},{"key":"12851_CR32","doi-asserted-by":"publisher","unstructured":"Ni, J., Ye, Y., Teng, F. & Wu, Q. Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis. Int. J. Gynecol. Cancer. 23 (1), 126\u2009\u2013\u200933. https:\/\/doi.org\/10.1097\/IGC.0b013e318274b1a2 (2013).","DOI":"10.1097\/IGC.0b013e318274b1a2"},{"issue":"6","key":"12851_CR33","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/0300060514544388","volume":"42","author":"S Zhang","year":"2014","unstructured":"Zhang, S., Kong, Y., Li, Y. & Yin, Y. Interleukin-10 gene \u2013\u20091082 G\/A polymorphism in cervical cancer and cervical intraepithelial neoplasia: meta-analysis. J. Int. Med. Res. 42 (6), 1193\u20131201. https:\/\/doi.org\/10.1177\/0300060514544388 (2014).","journal-title":"J. Int. Med. Res."},{"key":"12851_CR34","doi-asserted-by":"publisher","unstructured":"Chagas, B.S. et al. An interleukin-10 gene polymorphism associated with the development of cervical lesions in women infected with human papillomavirus and using oral contraceptives. Infect. Genet. Evol. 19, 32\u201337. https:\/\/doi.org\/10.1016\/j.meegid.2013.06.016 (2013).","DOI":"10.1016\/j.meegid.2013.06.016"},{"issue":"4","key":"12851_CR35","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s13277-014-2836-6","volume":"36","author":"P Singhal","year":"2014","unstructured":"Singhal, P., Kumar, A., Bharadwaj, S., Hussain, S. & Bharadwaj, M. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma. Tumor Biology. 36 (4), 2287\u20132298. https:\/\/doi.org\/10.1007\/s13277-014-2836-6 (2014).","journal-title":"Tumor Biology"},{"issue":"6","key":"12851_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ijc.1543","volume":"94","author":"GA Stanczuk","year":"2001","unstructured":"Stanczuk, G. A. et al. Cancer of the uterine cervix May be significantly associated with a gene polymorphism coding for increased IL-10 production. Int. J. Cancer. 94 (6), 792\u2013794. https:\/\/doi.org\/10.1002\/ijc.1543 (2001).","journal-title":"Int. J. Cancer"},{"key":"12851_CR37","doi-asserted-by":"publisher","unstructured":"Sz\u00f6ke, K. et al. IL-10 promoter nt -1082A\/G polymorphism and human papillomavirus infection in cytologic abnormalities of the uterine cervix. J Interferon Cytokine Res. 24(4), 245\u2009\u2013\u200951 (2004). https:\/\/doi.org\/10.1089\/107999004323034114","DOI":"10.1089\/107999004323034114"},{"issue":"5","key":"12851_CR38","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s13277-012-0408-1","volume":"33","author":"G Barbisan","year":"2012","unstructured":"Barbisan, G., P\u00e9rez, L. O., Contreras, A. & Golijow, C. D. TNF-\u03b1 and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol. 33 (5), 1549\u20131556. https:\/\/doi.org\/10.1007\/s13277-012-0408-1 (2012).","journal-title":"Tumour Biol."},{"issue":"1","key":"12851_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0304-3835(02)00193-3","volume":"184","author":"JW Roh","year":"2002","unstructured":"Roh, J. W. et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 184 (1), 57\u201363. https:\/\/doi.org\/10.1016\/s0304-3835(02)00193-3 (2002).","journal-title":"Cancer Lett."},{"issue":"11","key":"12851_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/jjco\/hyq094","volume":"40","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto, K. et al. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women. Jpn J. Clin. Oncol. 40 (11), 1113\u20131116. https:\/\/doi.org\/10.1093\/jjco\/hyq094 (2010).","journal-title":"Jpn J. Clin. Oncol."},{"key":"12851_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cyto.2018.06.014","volume":"113","author":"BS Chagas","year":"2019","unstructured":"Chagas, B. S. et al. Significant association between IL10-1082\/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by human papillomavirus. Cytokine 113, 99\u2013104. https:\/\/doi.org\/10.1016\/j.cyto.2018.06.014 (2019).","journal-title":"Cytokine"},{"key":"12851_CR42","doi-asserted-by":"publisher","unstructured":"Bai, C. Y., Shi, X. Y., He, J., Xue, J. & Feng, Y. Association between IL-10 genetic variations and cervical cancer susceptibility in a Chinese population. Genet. Mol. Res. 15 (3). https:\/\/doi.org\/10.4238\/gmr.15038116 (2016).","DOI":"10.4238\/gmr.15038116"},{"issue":"3","key":"12851_CR43","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (3), 1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215 (1988).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"12851_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez, S., Gaunt, T. R. & Day, I. N. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 169 (4), 505\u2013514. https:\/\/doi.org\/10.1093\/aje\/kwn359 (2009).","journal-title":"Am. J. Epidemiol."},{"issue":"5566","key":"12851_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.296.5566.261b","volume":"296","author":"HM Cann","year":"2002","unstructured":"Cann, H. M. et al. A human genome diversity cell line panel. Science 296 (5566), 261\u2013262. https:\/\/doi.org\/10.1126\/science.296.5566.261b (2002).","journal-title":"Science"},{"issue":"7571","key":"12851_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","unstructured":"1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526 (7571), 68\u201374. https:\/\/doi.org\/10.1038\/nature15393 (2015).","journal-title":"Nature"},{"key":"12851_CR47","doi-asserted-by":"publisher","unstructured":"Landrum, M. J. et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 48 (D1). https:\/\/doi.org\/10.1093\/nar\/gkz972 (2020). D835-D844.","DOI":"10.1093\/nar\/gkz972"},{"key":"12851_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2307\/2342435","volume":"98","author":"RA Fisher","year":"1935","unstructured":"Fisher, R. A. The logic of inductive inference. J. R Stat. Soc. 98, 39\u201382. https:\/\/doi.org\/10.2307\/2342435 (1935).","journal-title":"J. R Stat. Soc."},{"issue":"1","key":"12851_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R Stat. Soc. Ser. B. 57 (1), 289\u2013300 (1995).","journal-title":"J. R Stat. Soc. Ser. B"},{"issue":"1","key":"12851_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12859-023-05184-5","volume":"24","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. RGT: a toolbox for the integrative analysis of high throughput regulatory genomics data. BMC Bioinform. 24 (1), 79. https:\/\/doi.org\/10.1186\/s12859-023-05184-5 (2023).","journal-title":"BMC Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12851-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12851-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12851-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:47:46Z","timestamp":1757335666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12851-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12851"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12851-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,3]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28330"}}